Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Histiocytosis, Sinus | 1 | 2019 | 25 | 0.79 | Why? |
| Metal-on-Metal Joint Prostheses | 1 | 2018 | 7 | 0.77 | Why? |
| Cardiotoxicity | 2 | 2019 | 365 | 0.75 | Why? |
| Anthracyclines | 1 | 2017 | 65 | 0.68 | Why? |
| Cardiac Tamponade | 1 | 2019 | 165 | 0.62 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.49 | Why? |
| Diagnostic Imaging | 1 | 2019 | 1044 | 0.43 | Why? |
| Cardiomyopathies | 2 | 2017 | 997 | 0.41 | Why? |
| Echocardiography | 2 | 2019 | 3661 | 0.35 | Why? |
| Magnetic Resonance Imaging, Cine | 4 | 2021 | 669 | 0.33 | Why? |
| Cardiovascular Abnormalities | 1 | 2021 | 72 | 0.21 | Why? |
| Magnetic Resonance Imaging | 5 | 2021 | 6551 | 0.21 | Why? |
| Pulmonary Artery | 2 | 2017 | 803 | 0.21 | Why? |
| Prosthesis Failure | 2 | 2018 | 195 | 0.20 | Why? |
| Coronary Artery Disease | 3 | 2019 | 2570 | 0.19 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.19 | Why? |
| Heart Neoplasms | 1 | 2019 | 77 | 0.18 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.18 | Why? |
| Biopsy, Needle | 1 | 2019 | 303 | 0.18 | Why? |
| Ventricular Dysfunction | 1 | 2019 | 150 | 0.18 | Why? |
| Hypertension, Pulmonary | 2 | 2017 | 970 | 0.18 | Why? |
| Multimodal Imaging | 2 | 2019 | 534 | 0.18 | Why? |
| Lymphoma, B-Cell | 1 | 2019 | 166 | 0.17 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.16 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.16 | Why? |
| Pulse Wave Analysis | 1 | 2017 | 221 | 0.16 | Why? |
| Magnetic Resonance Angiography | 1 | 2017 | 282 | 0.15 | Why? |
| Myocardial Reperfusion | 1 | 2017 | 168 | 0.15 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.15 | Why? |
| Pulmonary Circulation | 1 | 2017 | 207 | 0.15 | Why? |
| Rare Diseases | 1 | 2019 | 373 | 0.14 | Why? |
| Myocarditis | 2 | 2021 | 2731 | 0.14 | Why? |
| Vascular Stiffness | 1 | 2017 | 264 | 0.14 | Why? |
| Shock, Cardiogenic | 1 | 2021 | 700 | 0.13 | Why? |
| Exercise Test | 2 | 2017 | 911 | 0.13 | Why? |
| Cardiac Pacing, Artificial | 1 | 2015 | 160 | 0.13 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| Spleen | 1 | 2017 | 877 | 0.13 | Why? |
| Electric Countershock | 1 | 2015 | 284 | 0.12 | Why? |
| Death, Sudden, Cardiac | 1 | 2017 | 522 | 0.12 | Why? |
| Myocardial Ischemia | 1 | 2019 | 781 | 0.12 | Why? |
| Respiration | 1 | 2017 | 729 | 0.12 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.11 | Why? |
| Immunohistochemistry | 1 | 2019 | 2275 | 0.11 | Why? |
| Case-Control Studies | 5 | 2021 | 17671 | 0.11 | Why? |
| Fibrosis | 1 | 2014 | 800 | 0.11 | Why? |
| Myocardium | 3 | 2021 | 2323 | 0.11 | Why? |
| Heart | 2 | 2017 | 1791 | 0.11 | Why? |
| Pacemaker, Artificial | 1 | 2015 | 431 | 0.11 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.10 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.10 | Why? |
| Cardiac Catheterization | 1 | 2017 | 882 | 0.10 | Why? |
| Gadolinium | 2 | 2021 | 318 | 0.10 | Why? |
| Contrast Media | 3 | 2021 | 1011 | 0.10 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1573 | 0.09 | Why? |
| Defibrillators, Implantable | 1 | 2015 | 624 | 0.09 | Why? |
| London | 3 | 2020 | 2166 | 0.09 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Heart Diseases | 2 | 2015 | 3503 | 0.09 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.09 | Why? |
| Cardiovascular System | 1 | 2014 | 750 | 0.08 | Why? |
| Personnel, Hospital | 1 | 2020 | 2273 | 0.08 | Why? |
| Dyspnea | 1 | 2019 | 3847 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.07 | Why? |
| Thromboembolism | 1 | 2017 | 2101 | 0.07 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.07 | Why? |
| Predictive Value of Tests | 4 | 2021 | 9537 | 0.06 | Why? |
| Health Personnel | 4 | 2021 | 29646 | 0.06 | Why? |
| Humans | 21 | 2021 | 930598 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.06 | Why? |
| Ventricular Function, Left | 2 | 2021 | 1555 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.05 | Why? |
| United Kingdom | 1 | 2019 | 18046 | 0.05 | Why? |
| Transducers, Pressure | 1 | 2017 | 4 | 0.05 | Why? |
| Valsalva Maneuver | 1 | 2017 | 17 | 0.05 | Why? |
| Meglumine | 1 | 2017 | 26 | 0.04 | Why? |
| Cardiac Catheters | 1 | 2017 | 44 | 0.04 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.04 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.04 | Why? |
| Hand Strength | 1 | 2017 | 202 | 0.04 | Why? |
| Cardiac Imaging Techniques | 1 | 2019 | 357 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.04 | Why? |
| Reproducibility of Results | 3 | 2017 | 11304 | 0.04 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2021 | 881 | 0.04 | Why? |
| Cardiac Resynchronization Therapy Devices | 1 | 2015 | 64 | 0.04 | Why? |
| Organometallic Compounds | 1 | 2017 | 206 | 0.04 | Why? |
| Male | 10 | 2021 | 367725 | 0.04 | Why? |
| Risk Assessment | 1 | 2019 | 25439 | 0.04 | Why? |
| Troponin | 1 | 2021 | 1058 | 0.04 | Why? |
| Ultrasonography, Doppler | 1 | 2017 | 406 | 0.03 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Adenosine | 1 | 2017 | 509 | 0.03 | Why? |
| Cardiac Resynchronization Therapy | 1 | 2015 | 191 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Prosthesis Design | 1 | 2015 | 594 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| False Negative Reactions | 1 | 2017 | 1785 | 0.03 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.03 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.03 | Why? |
| Denmark | 1 | 2017 | 2654 | 0.03 | Why? |
| Vascular Diseases | 1 | 2017 | 846 | 0.02 | Why? |
| England | 1 | 2020 | 5116 | 0.02 | Why? |
| Coronary Angiography | 1 | 2017 | 2275 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2017 | 22971 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2021 | 3543 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Models, Statistical | 1 | 2020 | 5312 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Aged | 4 | 2019 | 215776 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Retrospective Studies | 2 | 2017 | 105322 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2017 | 88759 | 0.01 | Why? |
Manisty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(197)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_